Tina Gullotta - Net Worth and Insider Trading

Tina Gullotta Net Worth

The estimated net worth of Tina Gullotta is at least $3,118 dollars as of 2024-04-28. Tina Gullotta is the VP, Finance of Sunesis Pharmaceuticals Inc and owns about 586 shares of Sunesis Pharmaceuticals Inc (SNSS) stock worth over $3,118. Details can be seen in Tina Gullotta's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tina Gullotta has not made any transactions after 2020-05-29 and currently still holds the listed stock(s).

Transaction Summary of Tina Gullotta

To

Tina Gullotta Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tina Gullotta owns 2 companies in total, including Sunesis Pharmaceuticals Inc (SNSS) , and Viracta Therapeutics Inc (VIRX) .

Click here to see the complete history of Tina Gullotta’s form 4 insider trades.

Insider Ownership Summary of Tina Gullotta

Ticker Comapny Transaction Date Type of Owner
SNSS Sunesis Pharmaceuticals Inc 2020-05-29 VP & Finance
VIRX Viracta Therapeutics Inc 2020-04-28 VP & Finance

Tina Gullotta Latest Holdings Summary

Tina Gullotta currently owns a total of 1 stock. Tina Gullotta owns 586 shares of Sunesis Pharmaceuticals Inc (SNSS) as of May 29, 2020, with a value of $3,118.

Latest Holdings of Tina Gullotta

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SNSS Sunesis Pharmaceuticals Inc 2020-05-29 586 5.32 3,118

Holding Weightings of Tina Gullotta


Tina Gullotta Form 4 Trading Tracker

According to the SEC Form 4 filings, Tina Gullotta has made a total of 1 transactions in Sunesis Pharmaceuticals Inc (SNSS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sunesis Pharmaceuticals Inc is the acquisition of 171 shares on May 29, 2020, which cost Tina Gullotta around $1,980.

Insider Trading History of Tina Gullotta

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Tina Gullotta Trading Performance

GuruFocus tracks the stock performance after each of Tina Gullotta's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tina Gullotta is -25%. GuruFocus also compares Tina Gullotta's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tina Gullotta within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Tina Gullotta's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Tina Gullotta

Average Return

No transaction record over 1 year.

Outperforming Transactions

No transaction record over 1 year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -26.05 -25 -61.54
Relative Return to S&P 500(%) -26.34 -40.23 -81.05

Tina Gullotta Ownership Network

Ownership Network List of Tina Gullotta

No Data

Ownership Network Relation of Tina Gullotta


Tina Gullotta Owned Company Details

What does Sunesis Pharmaceuticals Inc do?

Who are the key executives at Sunesis Pharmaceuticals Inc?

Tina Gullotta is the VP & Finance of Sunesis Pharmaceuticals Inc. Other key executives at Sunesis Pharmaceuticals Inc include director & See Remarks Dayton Misfeldt , See Remarks Judith A. Fox , and See Remarks William P. Quinn .

Sunesis Pharmaceuticals Inc (SNSS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sunesis Pharmaceuticals Inc (SNSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sunesis Pharmaceuticals Inc (SNSS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sunesis Pharmaceuticals Inc (SNSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sunesis Pharmaceuticals Inc Insider Transactions

No Available Data

Tina Gullotta Mailing Address

Above is the net worth, insider trading, and ownership report for Tina Gullotta. You might contact Tina Gullotta via mailing address: Sunesis Pharmaceuticals,inc, 395 Oyster Point Blvd., Suite 400, South San Francisco Ca 94080.

Discussions on Tina Gullotta

No discussions yet.